Literature DB >> 22795650

Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.

Sofia Maraki1, Elpis Mantadakis, Lambros Michailidis, George Samonis.   

Abstract

PURPOSE: The purpose of this study was to determine the distribution and changes in the antibiotic susceptibilities of uropathogens isolated from adults with community-acquired urinary tract infections (CA-UTIs) in Crete, Greece, over a 6-year period.
METHODS: This study was performed with isolates from outpatients with UTIs, collected between 2005 and 2010. Isolates were identified by standard methods and antimicrobial susceptibility testing was performed using the disk diffusion method and the VITEK2 is an automated system used for identification and antimicrobial susceptibility testing of microorganisms (BioMerieux). To identify changes in susceptibility patterns, we compared results of the period 2005-2007 to those of the period 2008-2010. We also compared the antibiotic susceptibilities of isolates between males and females.
RESULTS: A total of 4011 community-acquired uropathogens were isolated during the period of 2005-2010. Escherichia coli was the most common organism and responsible for 68.9% of CA-UTIs, followed by Proteus mirabilis (6.8%), Klebsiella pneumoniae (6.4%) and enterococci (6%). A significant increase in resistance of E coli isolates was noted for β-lactams, monobactams, aminoglycosides, quinolones, and cotrimoxazole. The reverse trend was evident for nitrofurantoin. Higher resistance rates of community-acquired E coli and non-E coli Enterobacteriaceae were noted in males for ampicillin, amoxicillin plus clavulanic acid, cephalosporins, aminoglycosides, and quinolones. No significant sex differences were noted in the antibiotic susceptibility patterns of enterococci.
CONCLUSION: There is a concerning trend for increasing resistance among E coli and non-E coli Enterobacteriaceae responsible for CA-UTIs in Crete in recent years likely due to the inappropriate use of broad spectrum antibiotics, as a substitute for precise diagnostics and/or to increase the chances of therapeutic success.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795650     DOI: 10.1016/j.jmii.2012.05.012

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany.

Authors:  Michael Kresken; Barbara Körber-Irrgang
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

2.  Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children.

Authors:  Anna Calzi; Sara Grignolo; Ilaria Caviglia; Maria Grazia Calevo; Giuseppe Losurdo; Giorgio Piaggio; Roberto Bandettini; Elio Castagnola
Journal:  Eur J Pediatr       Date:  2016-08-24       Impact factor: 3.183

3.  Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Jesús Oteo; Adriana Ortega; Macarena Villar; M Carmen Conejo; Germán Bou; Maitane Aranzamendi-Zaldumbide; Emilia Cercenado; Mercè Gurguí; Luis Martínez-Martínez; María Merino; Alba Rivera; Antonio Oliver; Irene Weber; Alvaro Pascual; Rosa M Bartolomé; Juan José Gónzalez-López; José Campos
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

4.  Bacteriuria and asymptomatic infection in chronic patients with indwelling urinary catheter: The incidence of ESBL bacteria.

Authors:  Sorin Albu; Septimiu Voidazan; Doina Bilca; Monica Badiu; Andreea Truţă; Marian Ciorea; Alin Ichim; Diana Luca; Geanina Moldovan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

5.  Oral fosfomycin for the treatment of chronic bacterial prostatitis.

Authors:  Ilias Karaiskos; Lambrini Galani; Vissaria Sakka; Aikaterini Gkoufa; Odysseas Sopilidis; Dimitrios Chalikopoulos; Gerasimos Alivizatos; Eleni Giamarellou
Journal:  J Antimicrob Chemother       Date:  2019-05-01       Impact factor: 5.790

6.  Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection.

Authors:  Zohreh Ghalavand; Masoud Alebouyeh; Kiandokht Ghanati; Leila Azimi; Marjan Rashidan
Journal:  Gut Pathog       Date:  2020-09-09       Impact factor: 4.181

Review 7.  Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.

Authors:  Oyebola Fasugba; Anne Gardner; Brett G Mitchell; George Mnatzaganian
Journal:  BMC Infect Dis       Date:  2015-11-25       Impact factor: 3.090

8.  Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection.

Authors:  Maryam Sotoudeh Anvari; Mohammad Naderan; Mohammad Ali Boroumand; Saeed Shoar; Robab Bakhshi; Morteza Naderan
Journal:  Int J Microbiol       Date:  2014-06-29

9.  Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.

Authors:  Stéphanie Guyomard-Rabenirina; Joyce Malespine; Célia Ducat; Syndia Sadikalay; Mélanie Falord; Dorothée Harrois; Vincent Richard; Charles Dozois; Sébastien Breurec; Antoine Talarmin
Journal:  BMC Microbiol       Date:  2016-06-24       Impact factor: 3.605

10.  Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland.

Authors:  E Stefaniuk; U Suchocka; K Bosacka; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.